Translational Research

The Vancouver Prostate Centre is heavily focused on translational research, which is the ability to move laboratory discoveries through the checks and balances into clinical trials, and eventually to develop these research findings into new and more effective treatments.

PC-TRiADD is the Vancouver Prostate Centre’s Translational Research Initiative for Accelerated Discovery and Development.

This initiative dives down to the molecular level to understand prostate cancer progression and treatment resistance and uses that information to develop new services and products to improve cancer outcomes.

Funded by the Government of Canada as a Centre of Excellence for Commercialization and Research (CECR), PC-TRiADD also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

BMO Vancouver Marathon, May 7: Prostate Cancer Foundation BC fundraiser

Prostate Cancer Foundation BC has a fundraising page for participants in the BMO Vancouver Marathon on May 7th.  You can make a donation by clicking here, or contact PCF-BC for more information of how to help at prostatebceventsattelus [dot] net.

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.